Day 2: September 11, 2025 13:00-15:00
Objectives:
1. Explain the pharmacist’s unique contribution to designing and running randomized clinical trials.
2. Discuss Saudi-specific regulatory and operational challenges in pharmacist-led RCTs.
3. Describe best practices from case studies such as the R2D2 deprescribing trial and the BrainSAFE hybrid study.
4. Examine and adapt decentralized trial tools—e-consent, home drug delivery, tele-pharmacy follow-up—to the Saudi context.
5. Apply and master REDCap by creating error-free eCRFs, randomization modules, automated alerts, and monitoring dashboards.
6. Design a compelling SNIH-style biosketch that highlights pharmacist expertise and trial leadership.
7. Create a SPIRIT-compliant protocol and at least one high-impact SOPs ready for regulatory submission
UAN# 0662-0000-25-002-L99-P
Objectives:
1. Explain the pharmacist’s unique contribution to designing and running randomized clinical trials.
2. Discuss Saudi-specific regulatory and operational challenges in pharmacist-led RCTs.
3. Describe best practices from case studies such as the R2D2 deprescribing trial and the BrainSAFE hybrid study.
4. Examine and adapt decentralized trial tools—e-consent, home drug delivery, tele-pharmacy follow-up—to the Saudi context.
5. Apply and master REDCap by creating error-free eCRFs, randomization modules, automated alerts, and monitoring dashboards.
6. Design a compelling SNIH-style biosketch that highlights pharmacist expertise and trial leadership.
7. Create a SPIRIT-compliant protocol and at least one high-impact SOPs ready for regulatory submission
UAN# 0662-0000-25-002-L99-P
Speakers
-
-
Dr. Khalid Alamer
